{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T20:32:21Z","timestamp":1762374741796},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2002,11,26]],"date-time":"2002-11-26T00:00:00Z","timestamp":1038268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,11,26]],"date-time":"2002-11-26T00:00:00Z","timestamp":1038268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1038\/sj.leu.2402770","type":"journal-article","created":{"date-parts":[[2002,11,28]],"date-time":"2002-11-28T11:59:38Z","timestamp":1038484778000},"page":"2358-2365","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)"],"prefix":"10.1038","volume":"16","author":[{"given":"B","family":"Wassmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"Scheuring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SA","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"G\u00f6kbuget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Binckebanck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Gschaidmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Hoelzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"OG","family":"Ottmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,11,26]]},"reference":[{"key":"BF2402770_CR1","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/S0889-8588(05)70188-X","volume":"14","author":"N G\u00f6kbuget","year":"2000","unstructured":"G\u00f6kbuget N, Hoelzer D, Arnold R . Treatment of adult ALL according to the protocols of the German multicenter study group for adult ALL (GMALL) Hematol Oncol Clin North Am 2000 14: 1307\u20131325","journal-title":"Hematol Oncol Clin North Am"},{"key":"BF2402770_CR2","first-page":"540","volume":"27","author":"D Hoelzer","year":"2000","unstructured":"Hoelzer D, G\u00f6kbuget N . New approaches in acute lymphoblastic leukemia in adults: where do we go? Semin Oncol 2000 27: 540\u2013559","journal-title":"Semin Oncol"},{"key":"BF2402770_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0889-8588(05)70198-2","volume":"15","author":"JP Radich","year":"2001","unstructured":"Radich JP . Philadelphia chromosome-positive acute lymphocytic leukemia Hematol Oncol Clin North Am 2001 15: 21\u201336","journal-title":"Hematol Oncol Clin North Am"},{"key":"BF2402770_CR4","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1182\/blood.V97.6.1572","volume":"97","author":"JJ Cornelissen","year":"2001","unstructured":"Cornelissen JJ, Carston M, Kollman C, King R, Dekker AW, Lowenberg B, Anasetti C . Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome Blood 2001 97: 1572\u20131577","journal-title":"Blood"},{"key":"BF2402770_CR5","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1038\/sj.leu.2401589","volume":"13","author":"DS Snyder","year":"1999","unstructured":"Snyder DS, Nademanee AP, O'Donnell MR, Parker PM, Stein AS, Margolin K, Somlo G, Molina A, Spielberger R, Kashyap A, Fung H, Slovak ML, Dagis A, Negrin RS, Amylon MD, Blume KG, Forman SJ . Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission Leukemia 1999 13: 2053\u20132058","journal-title":"Leukemia"},{"key":"BF2402770_CR6","first-page":"365","volume":"17","author":"LC Dunlop","year":"1996","unstructured":"Dunlop LC, Powles R, Singhal S, Treleaven JG, Swansbury GJ, Meller S, Pinkerton CR, Horton C, Mehta J . Bone marrow transplantation for Philadelphia chromosome-positive acute lympho-blastic leukemia Bone Marrow Transplant 1996 17: 365\u2013369","journal-title":"Bone Marrow Transplant"},{"key":"BF2402770_CR7","first-page":"663","volume":"16","author":"M Stockschlader","year":"1995","unstructured":"Stockschlader M, Hegewisch-Becker S, Kruger W, Tom DA, Mross K, Hoffknecht M, Berger C, Kohlschutter B, Martin H, Peters S . Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemia Bone Marrow Transplant 1995 16: 663\u2013667","journal-title":"Bone Marrow Transplant"},{"key":"BF2402770_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0889-8588(05)70201-X","volume":"15","author":"TG Martin","year":"2001","unstructured":"Martin TG, Gajewski JL . Allogeneic stem cell transplantation for acute lymphocytic leukemia in adults Hematol Oncol Clin North Am 2001 15: 97\u2013120","journal-title":"Hematol Oncol Clin North Am"},{"key":"BF2402770_CR9","first-page":"187","volume":"I","author":"H Martin","year":"2001","unstructured":"Martin H, Atta J, Klein SA, Fauth F, Bunjes D, Finckenstein F, Knauf W, Kolbe K, Kuse R, Langer W, Wassmann B, Weiss A, Hoelzer D . Autologous BMT\/PBSCT in 40 patients with bcr-abl positive acute lymphoblastic leukemia: long-term follow-up of a GMALL study The Hematology Journal 2001 I: 187 (Abstr.)","journal-title":"The Hematology Journal"},{"key":"BF2402770_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0889-8588(05)70204-5","volume":"15","author":"G Garcia-Manero","year":"2001","unstructured":"Garcia-Manero G, Thomas DA . Salvage therapy for refractory or relapsed acute lymphocytic leukemia Hematol Oncol Clin North Am 2001 15: 163\u2013205","journal-title":"Hematol Oncol Clin North Am"},{"key":"BF2402770_CR11","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M . Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome N Engl J Med 2001 344: 1038\u20131042","journal-title":"N Engl J Med"},{"key":"BF2402770_CR12","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1182\/blood-2001-12-0181","volume":"100","author":"OG Ottmann","year":"2002","unstructured":"Ottmann OG, Druker BJ, Sawyers CL, Goldman JM, Reiffers J, Silver RT, Tura S, Fischer T, Deininger M, Schiffer C, Baccarani M, Gratwohl A, Hochhaus A, Hoelzer D, Fernandes-Reese S, Gathman I, Capdeville R, O'Brien S . G. A phase II study of Glivec (imatinib mesylate) in patients with relapsed or refractory Philadelphia chromosome-positive acute leukemias Blood 2002 100: 1965\u20131971","journal-title":"Blood"},{"key":"BF2402770_CR13","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood.V90.4.1410","volume":"90","author":"J Sierra","year":"1997","unstructured":"Sierra J, Radich J, Hansen JA, Martin PJ, Petersdorf EW, Bjerke J, Bryant E, Nash RA, Sanders JE, Storb R, Sullivan KM, Appelbaum FR, Anasetti C . Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia Blood 1997 90: 1410\u20131414","journal-title":"Blood"},{"key":"BF2402770_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0140-6736(02)07679-1","volume":"359","author":"N Von Bubnoff","year":"2002","unstructured":"Von Bubnoff N, Schneller F, Peschel C, Duyster J . BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukemia to STI571 Lancet 2002 359: 487\u2013491","journal-title":"Lancet"},{"key":"BF2402770_CR15","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1182\/blood.V99.5.1860","volume":"99","author":"WK Hofmann","year":"2002","unstructured":"Hofmann WK, Jones LC, Lemp NA, de Vos S, Gschaidmeier H, Hoelzer D, Ottmann OG, Koeffler HP . Ph+ acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 (Glivec) has a unique BCR-ABL gene mutation Blood 2002 99: 1860\u20131862","journal-title":"Blood"},{"key":"BF2402770_CR16","first-page":"2585a","volume":"98","author":"RR Hoover","year":"2001","unstructured":"Hoover RR, Mahon FX, Melo JV, Daley GQ . Overcoming STI571 resistance with the farnesyltransferase inhibitor SCH66336 Blood 2001 98: 2585a (Abstr.)","journal-title":"Blood"},{"key":"BF2402770_CR17","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1182\/blood.V97.7.1999","volume":"97","author":"Y Kano","year":"2001","unstructured":"Kano Y, Akutsu M, Tsunoda S, Mano H, Sato Y, Honma Y, Furukawa Y . In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents Blood 2001 97: 1999\u20132007","journal-title":"Blood"},{"key":"BF2402770_CR18","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1182\/blood.V97.5.1404","volume":"97","author":"DG Peters","year":"2001","unstructured":"Peters DG, Hoover RR, Gerlach MJ, Koh EY, Zhang H, Choe K, Kirschmeier P, Bishop WR, Daley GQ . Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR\/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia Blood 2001 97: 1404\u20131412","journal-title":"Blood"},{"key":"BF2402770_CR19","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1182\/blood.V96.9.3195","volume":"96","author":"JT Thiesing","year":"2000","unstructured":"Thiesing JT, Ohno-Jones S, Kolibaba KS, Druker BJ . Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr-abl-positive cells Blood 2000 96: 3195\u20133199","journal-title":"Blood"},{"key":"BF2402770_CR20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/sj.leu.2402041","volume":"15","author":"J Topaly","year":"2001","unstructured":"Topaly J, Zeller WJ, Fruehauf S . Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells Leukemia 2001 15: 342\u2013347","journal-title":"Leukemia"},{"key":"BF2402770_CR21","first-page":"587a","volume":"98","author":"G Visani","year":"2001","unstructured":"Visani G, Isidori A, Malagola M, Alberti D, Piccaluga P, Martinelli G, Amabile M, Grafone T, Delfini C, Tura S, Baccarani M . Efficacy of Glivec (STI571) in conjunction with alpha-interferon in a case of relapsed p190 BCR-ABL positive acute lymphoblastic leukemia Blood 2001 98: 587a\u2013588a (Abstr.)","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402770.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402770","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402770.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:50:18Z","timestamp":1648763418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,26]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["BF2402770"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402770","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11,26]]},"assertion":[{"value":"24 May 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}